Back to School: How biopharma can reboot drug development. Access exclusive analysis here

PR1 vaccine: Phase I/II data

In a Phase I/II trial in 66 patients, PR1 produced

Read the full 104 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE